RV001V
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for RV001V, covering 2020-06-09 to 2021-09-28. Get the full timeline:
Most recent: Clinical Trial Update: Study of RV001V in Biochemical Failure Following Curatively Intended Therapy For Localized Prostate Cancer [Phase 2]